Literature DB >> 21293010

Tissue factor pathway inhibitor: a new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal women.

Veronique Regnault1, Christine Perret-Guillaume, Anna Kearney-Schwartz, Jean-Pierre Max, Carlos Labat, Huguette Louis, Denis Wahl, Bruno Pannier, Thomas Lecompte, Georges Weryha, Pascal Challande, Michel E Safar, Athanase Benetos, Patrick Lacolley.   

Abstract

OBJECTIVE: To investigate in women older than 60 whether aortic stiffness or pulse pressure (PP) is associated with selected procoagulant or anticoagulant factors and to examine whether pulsatile stretch influences these factors in human vascular smooth muscle cells (VSMCs) in vitro. METHODS AND
RESULTS: Aortic pulse wave velocity (PWV) and carotid PP were studied in 123 apparently healthy postmenopausal women. PWV, PP, von Willebrand factor, and free tissue factor pathway inhibitor (TFPI), but not mean arterial pressure, increased with age. Free TFPI and PWV were positively correlated, even after adjustment for age and PP and other confounding parameters. In vitro, 5% or 10% pulsatile stretch (at 1 Hz) enhanced TFPI synthesis and secretion by VSMCs in a time-independent manner (1 to 48 hours) without changes in protein level of smooth muscle myosin heavy chain. Application of 5% static stretch had no effect.
CONCLUSIONS: In postmenopausal women, free TFPI increases as vascular wall function deteriorates and PP increases. These findings are supported by the increase in TFPI synthesized by VSMCs in response to cyclic stress in vitro. They suggest that VSMCs require pulsatility to interfere with the coagulation process and highlight the relevance of plasma free TFPI levels to cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293010     DOI: 10.1161/ATVBAHA.110.221911

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  4 in total

1.  Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.

Authors:  Jacques E Rossouw; Karen C Johnson; Mary Pettinger; Mary Cushman; Per Morten Sandset; Lewis Kuller; Frits Rosendaal; Jan Rosing; Sylvia Wasserthal-Smoller; Lisa W Martin; Joann E Manson; Kamakshi Lakshminarayan; Jose G Merino; John Lynch
Journal:  Stroke       Date:  2012-02-23       Impact factor: 7.914

2.  Individual 6-year systolic blood pressure change and impact on cardiovascular mortality in a French general population.

Authors:  B Pannier; F Thomas; O Hanon; S Czernichow; C Lemogne; T Simon; J-M Simon; N Danchin
Journal:  J Hum Hypertens       Date:  2015-05-28       Impact factor: 3.012

3.  Sex difference in cardiovascular risk: role of pulse pressure amplification.

Authors:  Véronique Regnault; Frédérique Thomas; Michel E Safar; Mary Osborne-Pellegrin; Raouf A Khalil; Bruno Pannier; Patrick Lacolley
Journal:  J Am Coll Cardiol       Date:  2012-05-15       Impact factor: 24.094

Review 4.  Pulse Wave Velocity in Postmenopausal Women.

Authors:  Hiromichi Suzuki; Kazuoki Kondo
Journal:  Pulse (Basel)       Date:  2013-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.